Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $468.98 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $89.27 | 5 | $0 (2023) |
| PFIZER INC. | $85.11 | 1 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $81.71 | 5 | $0 (2022) |
| Evoke Pharma, Inc. | $54.44 | 3 | $0 (2022) |
| Gilead Sciences, Inc. | $52.20 | 2 | $0 (2022) |
| Braintree Laboratories, Inc. | $38.09 | 2 | $0 (2022) |
| Ironwood Pharmaceuticals, Inc | $29.62 | 2 | $0 (2022) |
| Nestle HealthCare Nutrition Inc. | $23.50 | 1 | $0 (2022) |
| VIVUS LLC | $15.04 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $124.69 | 3 | PFIZER INC. ($85.11) |
| 2022 | $222.42 | 12 | Gilead Sciences, Inc. ($52.20) |
| 2021 | $121.87 | 7 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($68.41) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/12/2023 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $85.11 | General |
| Category: VACCINES | ||||||
| 02/13/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/02/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/22/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.35 | General |
| 11/22/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Gastroenterology | ||||||
| 06/21/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/07/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/24/2022 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.02 | General |
| Category: GI | ||||||
| 05/12/2022 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: GI COLON PREP | ||||||
| 05/11/2022 | Evoke Pharma, Inc. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Gastroenterology | ||||||
| 03/10/2022 | Evoke Pharma, Inc. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Gastroenterology | ||||||
| 02/22/2022 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $12.60 | General |
| Category: GI | ||||||
| 02/18/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/14/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.85 | General |
| 01/24/2022 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: GI COLON PREP | ||||||
| 12/16/2021 | VIVUS LLC | Pancreaze (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/01/2021 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Gastroenterology | ||||||
| 12/01/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Gastroenterology | ||||||
| 10/22/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/15/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Gastroenterology | ||||||
| 08/11/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Gastroenterology | ||||||
| 07/07/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 67 | 86 | $18,872 | $4,808 |
| 2022 | 4 | 295 | 362 | $77,290 | $21,493 |
| 2021 | 4 | 161 | 171 | $38,716 | $14,548 |
| 2020 | 3 | 66 | 69 | $13,476 | $5,109 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 53 | $10,600 | $2,862 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 22 | $4,664 | $1,124 | 24.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,608 | $822.16 | 22.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 179 | 243 | $48,600 | $11,961 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 60 | $12,720 | $4,466 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 40 | 40 | $13,120 | $4,155 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 19 | $2,850 | $911.30 | 32.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 85 | 91 | $19,138 | $7,812 | 40.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 40 | 40 | $13,024 | $4,624 | 35.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 25 | $3,554 | $1,352 | 38.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 15 | $3,000 | $760.67 | 25.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 28 | 28 | $5,740 | $2,185 | 38.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 26 | 29 | $3,944 | $1,526 | 38.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $3,792 | $1,398 | 36.9% |
About Prina Patel, APN, FNP-BC
Prina Patel, APN, FNP-BC is a Nurse Practitioner healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2019. The National Provider Identifier (NPI) number assigned to this provider is 1609427137.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Prina Patel, APN, FNP-BC has received a total of $468.98 in payments from pharmaceutical and medical device companies, with $124.69 received in 2023. These payments were reported across 22 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($468.98).
As a Medicare-enrolled provider, Patel has provided services to 589 Medicare beneficiaries, totaling 688 services with total Medicare billing of $45,958. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Nurse Practitioner
- Location Palo Alto, CA
- Active Since 09/25/2019
- Last Updated 12/09/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1609427137
Products in Payments
- PREVNAR 20 (Biological) $85.11
- ENTYVIO (Biological) $69.76
- XIFAXAN (Drug) $63.19
- GIMOTI (Drug) $54.44
- SUTAB (Drug) $38.09
- Linzess (Drug) $29.62
- ZENPEP (Drug) $23.50
- GATTEX (Drug) $19.51
- TRULANCE (Drug) $18.52
- Pancreaze (Drug) $15.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Palo Alto
Judith Lea, Np, NP
Nurse Practitioner — Payments: $7,480
Rachael Small, Arnp, ARNP
Nurse Practitioner — Payments: $5,050
Mrs. Megan Larsen, Crnp, CRNP
Nurse Practitioner — Payments: $4,639
Melissa Martz, Np, NP
Nurse Practitioner — Payments: $4,033
Fariba Hajy Iseyedsoleiman
Nurse Practitioner — Payments: $3,753
Janet Hall, Np, NP
Nurse Practitioner — Payments: $2,698